Moderna target nearly halved by Morgan Stanley on weak guidance
-- Morgan Stanley slashed its price target on Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) to $38 from $70 given the lowered revenue guidance and ongoing competitive...
-- Morgan Stanley slashed its price target on Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) to $38 from $70 given the lowered revenue guidance and ongoing competitive...
-- Shares of NeoGenomics, Inc. (NASDAQ: NASDAQ:NEO) rose 8% after the company provided an optimistic financial guidance for 2025 and updated its Long-Range Financial...
By Johann M Cherian and Sukriti Gupta (Reuters) - Wall Street's main indexes surged on Wednesday, with the benchmark S&P 500 at a one-week high, propelled by lower-than-expected...
By Manya Saini, Noor Zainab Hussain and Saeed Azhar (Reuters) - Goldman Sachs earned its biggest quarterly profit in more than three years, beating Wall Street expectations, as...
– Morocco stocks were higher after the close on Wednesday, as gains in the Food Producers & Processors, Holding Companies and Mining sectors led shares higher. At...
-- Shares of Rocket Companies (NYSE: RKT) and other real estate-related stocks like UWM Holdings Corporation (NYSE: UWMC), Fannie Mae (OTC: OTC:FNMA (ST:FNMA)), and...
-- Velan Inc. has announced its intention to sell its French subsidiaries, Segault SAS and Velan SAS, to Framatome, a unit of Electricite de France (EDF (EPA:EDF))....
-- Piper Sandler analysts highlighted a promising shift for Bitcoin miners in a note Wednesday, emphasizing the substantial earnings potential in pivoting towards AI...
-- Wolfspeed (NYSE:WOLF), a semiconductor device company, saw its shares rise by up to 20% after it reported the sale of its common stock shares through a previously...
-- Republican officials at the U.S. Securities and Exchange Commission (SEC) are preparing to revise the agency's cryptocurrency policies as early as next week,...